Chronic pain that responds to antisympathetic treatments and α-adrenergic antagonists is clinically referred to as sympathetically maintained pain. Animal models of neuropathic pain have shown mixed results in terms of antinociceptive effectiveness of antisympathetic agents. The effectiveness of these agents have not been yet investigated in animal models of complex regional pain syndrome-type 1 (CRPS-I). In this study, we examined the effectiveness of antisympathetic agents and sympathetic vasoconstrictor antagonists, as well as agents that are vasodilators, in relieving mechanical allodynia in a recently developed animal model of CRPS-I (chronic postischemia pain or CPIP) produced by three hours of hind paw ischemia-reperfusion injury. Systemic guanethidine, phentolamine, clonidine, and prazosin are effective in reducing mechanical allodynia particularly at 2 days after reperfusion, and less so at 7 days after reperfusion. A nitric oxide donor vasodilator, SIN-1, also reduces mechanical allodynia more effectively at 2 days after reperfusion, but not at 7 days after reperfusion. These results suggest that the pain of CPIP, and possibly also CRPS-I, is relieved by reducing sympathetically mediated vasoconstriction, or enhancing vasodilatation.
KeywordsComplex regional pain syndrome; ischemia-reperfusion injury; neuropathic pain; allodynia; sympathetic block; adrenergic receptors Complex regional pain syndrome-type I (CRPS-I) is a disorder that occurs after fracture, soft tissue or crush injury. 16 Symptoms of CRPS-I include spontaneous burning (cutaneous) and aching (deep) pain, hyperalgesia, allodynia, and disorders of vasomotor and sudomotor regulation. 27,57 CRPS-II is similar but also exhibits a clinically verified nerve injury.
CIHR Author Manuscript
CIHR Author Manuscript
CIHR Author ManuscriptAlthough controversial, sympathetic blocks are often reported to relieve CRPS pain. 10,29,68 CRPS pain is also relieved with α-adrenergic antagonists such as phentolamine or phenoxybenzamine, 48,52 agents that have been used as diagnostic tools for identifying socalled sympathetically maintained pain (SMP We recently introduced chronic postischemia pain (CPIP) as an animal model of CRPS-I produced after hind paw ischemia-reperfusion (I-R) injury.14 This animal model shows signs of I-R injury such as no-reflow and vascular abnormalities, as well as nociceptive and vascular hypersensitivity to norepinephrine. 38,78 The pain-relieving effects of antisympathetic agents have not previously been tested in animal models of CRPS-I. 21,22,71 In this report, we examine whether antisympathetic drugs, and agents that are vasodilators, are effective in reducing painful symptoms in this model. Thus, we test the effectiveness of sympathetic block with guanethidine, or systemic treatments with the α1-and α2-adrenergic antagonists prazosin and yohimbine, the α2-adrenergic agonist clonidine, and a nitric oxide donor, in relieving mechanical allodynia in CPIP rats at 2 and 7 days after reperfusion.
Materials and Methods
Animal...